Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card
Table 1
Characteristics of qualitative interview participants.
Age (years)
Years since diagnosis
Risk level
Treatment/s received‡
74
Three
High
External beam radiotherapy and hormone
73
Two
Low
Low-dose brachytherapy
74
Three
High
External beam radiotherapy and hormone
68
Four
Advanced
Hormone/degarelix
85
Three
High
External beam radiotherapy and hormone/Eligard
68
Four and half
Low
Low-dose brachytherapy
69
Two
Advanced
Chemotherapy/docetaxel and hormone
71
One and half
Low
Active surveillance and then surgery
78
Two and half
Low
Active surveillance/watchful waiting—not sure
77
Three
High
External beam radiotherapy and hormone
70
Three and half
Low
External beam radiotherapy alone
67
One and half
Low
Low-dose brachytherapy
72
Two
High
Hormone alone
73
Five
Low
Active surveillance
Self-reported risk levels could be different from clinical reports due to difficulty in understanding risk definition. ‡Members of the consumer advisory group were predominantly men who had undergone radical prostatectomy, and hence we purposively selected other treatment types for this phase of feedback.
